Currie, 1994 - Google Patents
Clinical implications of research on the box-jellyfish Chironex fleckeriCurrie, 1994
- Document ID
- 12161292809238624024
- Author
- Currie B
- Publication year
- Publication venue
- Toxicon
External Links
Snippet
B. Currie. Clinical implications of research on the box-jellyfish Chironex fleckeri. Toxicon32, 1305–1313, 1994.—Despite several decades of laboratory research, many anecdotal clinical publications and successful production of antivenom, the active components of …
- 241000191257 Chironex fleckeri 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Currie | Clinical implications of research on the box-jellyfish Chironex fleckeri | |
| US5538740A (en) | Therapeutic and cosmetic compositions for treatment of skin | |
| Theakston et al. | Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom | |
| US4424232A (en) | Treatment of herpes simplex | |
| Bailey et al. | Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies | |
| JPS61204132A (en) | Wound healing by ghl-cu and use as antiinflammatory | |
| US4734279A (en) | Combination of immunoglobulins with therapeutic agents | |
| US5853768A (en) | Topical preparation and method for pain relief | |
| KR950015056B1 (en) | Pharmaceutical composition used to treat painful inflammatory or allergic diseases | |
| EP0531495B1 (en) | Therapeutic and cosmetic compositions for treatment of skin | |
| US4678668A (en) | Method of reducing soft tissue swelling and pain | |
| RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
| Kucera et al. | Effects of Symphytum ointment on muscular symptoms and functional locomotor disturbances | |
| Gertner | Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome | |
| US6048843A (en) | Topical composition containing amino acid in combination with either interferon of thymidine derivatives for treating viral or inflammation diseases | |
| US4162309A (en) | Water soluble extracts of certain marine red algae and processes for use thereof | |
| Henderson et al. | STINGOSE A NEW AND EFFECTIVE TREATMENT FOR BITES AND STINGS | |
| KUFLIK | Cryosurgical treatment of periungual warts | |
| GB2177918A (en) | Pharmaceutical compositions containing procaine | |
| Flachsenberger et al. | Anticholinesterases as antidotes to envenomation of rats by the death adder (Acanthophis antarcticus) | |
| KR0177137B1 (en) | labor pains. Inflammatory drugs | |
| RU2127110C1 (en) | Burn treatment means | |
| Smith | Effect of investigator bias on clinical trials | |
| US9999643B2 (en) | Therapeutic composition for treating gangrene | |
| US5977176A (en) | Compositions for the treatment of warts and herpes |